Pfizer, Serum File EUAs For COVID-19 Vaccines In India

Questions Remain Over Serum's Adverse Event

 
• By Vibha Ravi
As COVID-19 Vaccines Zip Ahead To Launch, Questions Linger • Source: Shutterstock

More from Business

More from Scrip